Saltar al contenido

The Evidence Base

@theevidencebase.bsky.social did:plc:pb4wpto3rgocga55xxqs6ecg

Providing the latest news, opinion and insight into hot topics including real-world data, health economics and outcomes research and patient-centric care.

En Bluesky desde el

Seguidores
119
Siguiendo
72
Posts
608
Días en rankings
0

Resumen

The Evidence Base (@theevidencebase.bsky.social) es un usuario de Bluesky que se unió el 6 diciembre 2024. Tiene 119 seguidores, sigue a 72 cuentas y ha publicado 608 posts.

Apariciones en rankings

Los mejores días en que los posts de esta cuenta entraron en la lista diaria de Debya.

Esta cuenta aún no ha aparecido en un ranking diario.

Posts que le gustaron recientemente

Me gusta públicos de la red Bluesky.

  • Journal of Comparative Effectiveness Research@journal-cer.bsky.social

    📢New article alert Treatment burden and healthcare resource utilization in patients with chronic rhinosinusitis with nasal polyps who did or did not undergo functional endoscopic sinus surgery: a US real-world retrospective cohort study 🔗 becarispublishing.com/doi/10.57264... #OpenAccess #JCER

    Ver post
  • Journal of Comparative Effectiveness Research@journal-cer.bsky.social

    📢New article alert New Perspective article on "Sieving for gold: external comparator studies to prioritize drugs for late-stage clinical trial" 🔗Read here: becarispublishing.com/doi/10.57264... #OpenAccess #JCER #TrialMethodology #RealWorldEvidence #RWE

    Ver post
  • Journal of Comparative Effectiveness Research@journal-cer.bsky.social

    📢New article alert New Research Article on “Indirect comparisons of tucatinib in combination with trastuzumab for patients with previously treated HER2–positive metastatic colorectal cancer”. 🔗Read here: becarispublishing.com/doi/10.57264... #OpenAccess #JCER #ColorectalCancer #Oncology #ITC

    Ver post
  • Journal of Comparative Effectiveness Research@journal-cer.bsky.social

    📢New Research Article alert "Acthar Gel versus standard of care for adults with proteinuria in nephrotic syndrome due to focal segmental glomerulosclerosis: cost-per-response analysis from the US healthcare perspective" 🔗 becarispublishing.com/doi/10.57264... #OpenAccess #JCER #KidneyDisease

    Ver post
  • Journal of Comparative Effectiveness Research@journal-cer.bsky.social

    📢New article alert New Short Report on "First-line tumor necrosis factor inhibitor versus abatacept treatment choice in real-world patients with anticitrullinated protein antibody- and rheumatoid factor-positive rheumatoid arthritis". 🔗Read here: becarispublishing.com/doi/10.57264... #OpenAccess

    Ver post

Inicia sesión para ver más

Cuentas que bloquea

En Bluesky los bloqueos son registros públicos.

Esta cuenta no bloquea a nadie.